Analysis of the Demographic and Clinical Characteristics of Tuberculosis Patients to Strengthen Tuberculosis Control Strategies at Way Kandis Primary Health Center, Bandar Lampung City
DOI:
https://doi.org/10.53089/medula.v17i2.2049Keywords:
epidemiologi, TB paru, TB sensitif obat, Tes Cepat MolekulerAbstract
Tuberculosis (TB) remains a major public health problem worldwide, including Indonesia. Understanding the epidemiological characteristics of TB cases is essential for planning effective TB control programs. This study aimed to describe the demographic and clinical characteristics of TB patients in the working area of Way Kandis Public Health Center, Bandar Lampung City, Indonesia. This retrospective descriptive study included TB cases recorded from July 2023 to June 2026. Data were obtained from the Tuberculosis Information System (SITB) and TB 03 and TB 06 reporting forms. Variables included age, sex, TB type and classification, anatomical site, occupation, type 2 diabetes mellitus (T2DM), HIV status, rapid molecular test (RMT) results, and residential area. Univariate analysis was performed to determine frequency distributions and percentages. Among 356 TB cases, 59.83% involved patients aged 15–59 years, and 59.83% were male. Clinically diagnosed TB accounted for 54.78% of cases, while bacteriologically confirmed TB accounted for 45.22%. Most cases were new cases (96.91%) and pulmonary TB (90.45%). Unemployment was reported in 67.98% of patients. T2DM and HIV positivity were identified in 4.49% and 1.40% of cases, respectively. All bacteriologically confirmed pulmonary TB cases tested by RMT were rifampicin-susceptible (100%). A total of 20.22% of patients resided in Way Kandis Urban Village. TB cases predominantly affected individuals of productive age, with clinically diagnosed TB, new cases, and pulmonary TB being the most common characteristics. These findings highlight the importance of early case detection, contact investigation, transmission prevention, and treatment outcome monitoring.
References
World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization; 2025.
Kementerian Kesehatan Republik Indonesia. Kenali kelompok yang berisiko tinggi tertular TBC [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2025. Tersedia dari: https://www.kemkes.go.id/id/kenali-ke-lompok-yang-berisiko-tinggi-tertular-tbc.
World Health Organization Indonesia. 2025. Laporan hasil studi inventori tuberkulosis Indonesia 2023-2024. Jakarta: WHO Indonesia; 2025.
Kementerian Kesehatan Republik Indonesia, Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Laporan tuberkulosis nasional 2023: menuju eliminasi TB 2030. Jakarta: Kementerian Kesehatan Republik Indonesia; 2023.
Apriani, N. Karakteristik penderita tuberkulosis paru di Puskesmas. Jurnal Keperawatan dan Kesehatan. 2021;12(2):145-152.
Dabitao D, Bishai WR. Sex and gender differences in tuberculosis pathogenesis and treatment outcomes. Int J Tuberc Lung Dis. 2023;27(8):589-596.
Van AC, Storms I, Kurver L, Smeenk FWJM, Wielders P, Hoefsloot W, dkk. Elderly patients with tuberculosis in a low-incidence country: clinical characteristics, inflammation and outcome. J Infect. 2024;89(2):106200. doi:10.1016 /j.jinf. 2024.106200
Sumpter C, Chandramohan D. Association between indoor air pollution, tobacco smoke and tuberculosis: an updated systematic review and meta-analysis. Public Health. 2020;187:24-35.
Freitag B, Sultanli A, Grilli M, Weber SF, Gaeddert M, Abdullahi OA, dkk. Clinically diagnosed tuberculosis and mortality in high burden settings: a systematic review and meta-analysis. eClinicalMedicine. 2025;84:103251. doi:10.1016/j.eclinm. 2025.103251.
Zaenab S, Ronoatmodjo S, Putri M. Gambaran diagnosis TBC di Indonesia tahun 2020-2022. J Epidemiol Kesehat Indones. 2024;8(1):8. doi:10.7454/epid-kes.v8i1.1099.
Karuniawati A, Burhan E, Koendhori EB, Sari D, Haryanto B, Nuryastuti T, dkk. Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia. Front Med. 2022;9:909198. doi:10.3389/fmed.2022. 909198.
Vega V, Cabrera-Sanchez J, Rodríguez S, Verdonck K, Seas C, Otero L, dkk. Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis. BMJ Open Respir Res. 2024;11(1). doi:10.1136/bmjresp-2023-002281.
Sinha R, Fitriangga A, Sharan AP, Zaman SU, Putra IWGAE, Alex A. Prevalence of lost to follow-up in drug-sensitive TB patients in WHO South-East Asia Region: a systematic review and meta-analysis. Indian J Tuberc. 2026;73(2):261-9. doi:10.1016/j.ijtb.2026.01.008.
Ginting MAB, Batubara HJS, Hapsah, Sari MT. Association between anti-tuberculosis drug (OAT) adherence and tuberculosis recurrence among pulmonary TB patients at Dr. Pirngadi Regional Hospital, Medan. J Kesehat Kedokt. 2026;5(1):357-70. doi:10.56127/ jukeke.v5i1.2582.
Ayu DD, Hasibuan SR, Pradnyani PE. Dominant factors of recurrent tuberculosis treatment visits in Jakarta: faktor dominan kunjungan berulang pengobatan tuberkulosis di DKI Jakarta. Academia Open. 2026:11(1). doi:10.21070/acopen.11.2026.12985.
Kementerian Kesehatan Republik Indonesia. Laporan program penanggulangan tuberkulosis Indonesia 2024. Jakarta: Kementerian Kesehatan Republik Indonesia; 2024.
Sharma SK, Mohan A, Kohli M. Extrapulmonary tuberculosis. Expert Rev Respir Med. 2021;15(7):931-48. doi:10.1080/17476348.20 21.1927718.
Jeong YJ, Kang JY, Kim HW, Min J, Ko Y, Oh JY, dkk. Association of underlying comorbidities and sites of tuberculosis: an analysis using surveillance data. BMC Pulm Med. 2022;22:417. doi:10.1186/ s12890-022-02224-3.
Diriba G, Alemu A, Eshetu K, Yenew B, Gamtesa DF, Tola HH. Bacteriologically confirmed extrapulmonary tuberculosis and the associated risk factors among extrapulmonary tuberculosis suspected patients in Ethiopia: A systematic review and meta-analysis. PLoS One. 2022;17(11):e0276701. doi:10.1371/jour-nal.pone.0276701.
Singhal L, Gupta P, Noorul Aysha K, Gupta V. Insights into changing patterns of extrapulmonary tuberculosis in North India. Indian J Med Microbiol. 2024;50:100657. doi:10.1016/j. ijmmb. 2024.100657.
Arisandi D, Sugiarti W, Islamarida R. Karakteristik penderita tuberkulosis paru di Kabupaten Sleman, D.I. Yogyakarta. J Formil (Forum Ilmiah) Kesmas Respati. 2023;8(1). doi:10.35842/formil.v8i1.470.
Main S, Triasih R, Greig J, Hidayat A, Brilliandi IB, Khodijah S, dkk. The prevalence and risk factors for tuberculosis among healthcare workers in Yogyakarta, Indonesia. PLoS One. 2023;18(5):e0279215. doi:10.1371/jour-nal.po ne.0279215.
Alemu A, Bitew ZW, Diriba G, Gumi B. Risk factors associated with drug-resistant tuberculosis in Ethiopia: a systematic review and meta-analysis. Transbound Emerg Dis. 2022;69(5):2559-2572. doi:10.1111/tbed.14378.
Taal AT, Barreto JG, Dos Santos de Sousa G, Medeiros da Rocha A, Lima Ferreira NN, Menezes da Silva JA, dkk. The geographical distribution and socioeconomic risk factors of COVID-19, tuberculosis and leprosy in Fortaleza, Brazil. BMC Infect Dis. 2023;23:662. doi:10.1186/s12879-023-08627-9.
World Health Organization, The Union. Framework for collaborative activities on tuberculosis and diabetes mellitus. Geneva: World Health Organization; 2022.
Foe-Essomba JR, Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, Mbaga DS, Kengne-Ndé C, dkk. Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders. PLoS One. 2021:16(12). doi:10.1371/jour-nal.pone.0261246.
Xu G, Hu X, Lian Y, Zhang Y, Li J, Wang Y, dkk. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2023;23:813. doi:10.1186/s12879-023-08765-0.
Alemu A, Bitew ZW, Diriba G, Gumi B. 2021. Co-occurrence of tuberculosis and diabetes mellitus, and associated risk factors, in Ethiopia: a systematic review and meta-analysis. IJID Reg. 2022;1:82-91. doi:10.1016/j.ijregi.2021.10.004.
Du Q, Wang L, Long Q, Zhao Y, Abdullah AS. Systematic review and meta-analysis: prevalence of diabetes among patients with tuberculosis in China. Trop Med Int Health. 2021;26(12):1553-9. doi:10.1111/ tmi.13686.
Foe-Essomba JR, Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, Mbaga DS, Kengne-Ndé C, dkk. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis. Sci Rep. 2021;11:574. doi:10.1038/s41598-021-81057-2.
Machrumnizar, Eryando T, Bachtiar A, Kusumaratna RK, Meiyanti, Djuana E, dkk. Understanding the epidemiology of TB-HIV co-infection in Indonesia: evidence from the 2023 national TB registry. BMJ Public Health. 2025;3.
Grover S, Chawla G, Parihar HL, Niwas R, Saxena A, Khangarot S, dkk. Human immunodeficiency virus infection amongst newly diagnosed tuberculosis patients and their clinico-radiological profile: a prospective study from Western India. J Family Med Prim Care. 2020;9(5):2475-9. doi:10.4103/jfmpc. jfmpc_121_20.
Nyasulu PS, Ngasama E, Tamuzi JL, Sigwadhi LN, Ozougwu LU, Nhandara RBC, dkk. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa. PLoS One. 2022;17(10). doi:10.1371/journal. pone.0274549.
Wondmeneh TG, Mekonnen AT. The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis. 2023;23:613. doi:10.1186/s12879-023-08533-0.
Karuniawati A, Burhan E, Koendhori EB, Sari D, Haryanto B, Nuryastuti T, dkk. Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia. Front Med. 2022;9:909198. doi:10.3389/fmed. 2022. 909198.
Iskandar D, Suwantika AA, Pradipta IS, Postma MJ, van Boven JFM. Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017-2019. Lancet Reg Health West Pac. 2023;31:100641. doi:10.1016/j.lanwpc. 2022.100641.
Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis. PLos One. 2022;17(6). doi:10.1371/journal.pone.0270003.
Naidoo K, Perumal R, Ngema SL, Shunmugam L, Somboro AM. Rapid diagnosis of drug-resistant tuberculosis-opportunities and challenges. Pathogens. 2024;13(1):27. doi:10.3390/pathogens-13010027.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
